Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 6, 2013, Pages 541-550

  Liepinsh, Edgars ^a   Skapare, Elina ^a,b   Kuka, Janis ^a   Makrecka, Marina ^a,b   Cirule, Helena ^a   Vavers, Edijs ^a,b   Sevostjanovs, Eduards ^a   Grinberga, Solveiga ^a   Pugovics, Osvalds ^a   Dambrova, Maija ^a,b  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

3 (2,2,2 Trimethylhydrazinium) propionate; Carnitine palmitoyltransferase I; Mitochondria; Peroxisomes; PPAR PGC1 pathway

Indexed keywords

3 (2,2,2 TRIMETHYLHYDRAZINIUM) PROPIONATE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; MESSENGER RNA; PALMITOYLCARNITINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROPIONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; GENE EXPRESSION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; MASS FRAGMENTOGRAPHY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION; PEROXISOME; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; FATTY ACIDS; GENE EXPRESSION REGULATION; MALE; METHYLHYDRAZINES; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; PEROXISOMES; PPAR ALPHA; RATS; RATS, WISTAR; TRANSCRIPTION FACTORS;

EID: 84878015345     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0849-0     Document Type: Article

References (36)

1. Asaka N, Muranaka Y, Kirimoto T, Miyake H (1998) Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts. Fundam Clin Pharmacol 12:158-163
2. Beauloye C, Bertrand L, Horman S, Hue L (2011) AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 90:224-233
3. Dambrova M, Liepinsh E, Kalvinsh I (2002) Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12:275-279
4. Dambrova M, Cirule H, Svalbe B, Zvejniece L, Pugovichs O, Zorenko T, Kalvinsh I, Liepinsh E, Belozertseva I (2008) Effect of inhibiting carnitine biosynthesis on male rat sexual performance. Physiol Behav 95:341-347
5. Degrace P, Demizieux L, Gresti J, Tsoko M, Andre A, Demaison L, Clouet P (2004) Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat. Mol Cell Biochem 258:171-182
6. Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H (1999) Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg 67:1682-1688
7. Duncan JG (2011) Peroxisome proliferator activated receptor-alpha (PPARalpha) and PPAR gamma coactivator-1alpha (PGC-1alpha) regulation of cardiac metabolism in diabetes. Pediatr Cardiol 32:323-328
8. Finck BN, Kelly DP (2007) Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115:2540-2548
9. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375:637-649
10. Harrison EH, Walusimbi-Kisitu M (1988) Properties and subcellular localization of myocardial fatty acyl-coenzyme A oxidase. Am J Physiol 255:H441-H445
11. Hayashi Y, Tajima K, Kirimoto T, Miyake H, Matsuura N (2000) Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts. Pharmacology 61:238-243
12. Kim M, Tian R (2011) Targeting AMPK for cardiac protection: opportunities and challenges. J Mol Cell Cardiol 51:548-553
13. Kono K, Kamijo Y, Hora K, Takahashi K, Higuchi M, Kiyosawa K, Shigematsu H, Gonzalez FJ, Aoyama T (2009) PPAR{alpha} attenuates the proinflammatory response in activated mesangial cells. Am J Physiol Renal Physiol 296:F328-F336
14. Korge P, Honda HM, Weiss JN (2003) Effects of fatty acids in isolated mitochondria: implications for ischemic injury and cardioprotection. Am J Physiol Heart Circ Physiol 285:H259-H269
15. Kuka J, Vilskersts R, Cirule H, Makrecka M, Pugovics O, Kalvinsh I, Dambrova M, Liepinsh E (2012) The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine. J Cardiovasc Pharmacol Ther 17:215-222
16. Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M (2006) Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. J Cardiovasc Pharmacol 48:314-319
17. Liepinsh E, Vilskersts R, Zvejniece L, Svalbe B, Skapare E, Kuka J, Cirule H, Grinberga S, Kalvinsh I, Dambrova M (2009) Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats. Br J Pharmacol 157:1549-1556
18. Liepinsh E, Kalvinsh I, Dambrova M (2011a) The regulation of energy metabolism pathways through L-carnitine homeostasis. In: Croniger C (ed) Role of the adipocyte in development of type 2 diabetes. InTech, Rijeka, pp 107-128
19. Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M (2011b) Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol 658:277-283
20. Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M (2011c) Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol 658:277-283
21. Lopaschuk GD, Barr RL (1997) Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol Cell Biochem 172:137-147
22. Luiken JJ, Niessen HE, Coort SL, Hoebers N, Coumans WA, Schwenk RW, Bonen A, Glatz JF (2009) Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem J 419:447-455
23. Poirier Y, Antonenkov VD, Glumoff T, Hiltunen JK (2006) Peroxisomal beta-oxidation - a metabolic pathway with multiple functions. Biochim Biophys Acta 1763:1413-1426
24. Ravingerova T, Adameova A, Carnicka S, Nemcekova M, Kelly T, Matejikova J, Galatou E, Barlaka E, Lazou A (2011) The role of PPAR in myocardial response to ischemia in normal and diseased heart. Gen Physiol Biophys 30:329-341
25. Schurch R, Todesco L, Novakova K, Mevissen M, Stieger B, Krahenbuhl S (2010) The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats. Eur J Pharmacol 635:171-176
26. Sebastian D, Guitart M, Garcia-Martinez C, Mauvezin C, Orellana-Gavalda JM, Serra D, Gomez-Foix AM, Hegardt FG, Asins G (2009) Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells. J Lipid Res 50:1789-1799
27. Shriver LP, Manchester M (2011) Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci Rep 1:79
28. Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB (2000) A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 279:H2124-H2132
29. Srere PA (1963) Citryl-CoA an substrate for the citrate-cleavage enzyme. Biochim Biophys Acta 73:523-525
30. Sugden MC, Zariwala MG, Holness MJ (2009) PPARs and the orchestration of metabolic fuel selection. Pharmacol Res 60:141-150
31. Tominaga H, Katoh H, Odagiri K, Takeuchi Y, Kawashima H, Saotome M, Urushida T, Satoh H, Hayashi H (2008) Different effects of palmitoyl-L-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 295:H105-H112
32. Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, Oka T, Wagg CS, Jaswal JS, Harris RA, Clanachan AS, Dyck JR, Lopaschuk GD (2012) Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res 94:359-369
33. Vilskersts R, Liepinsh E, Mateuszuk L, Grinberga S, Kalvinsh I, Chlopicki S, Dambrova M (2009) Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice. Pharmacology 83:287-293
34. Wang W, Lopaschuk GD (2007) Metabolic therapy for the treatment of ischemic heart disease: reality and expectations. Expert Rev Cardiovasc Ther 5:1123-1134
35. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW Jr (1990) Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 184:193-199
36. Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH (2003) Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation 108:2393-2399